March 07, 2026 | 14:30

Thanh Hoa approves $56mln Vietnam–India high-tech pharmaceutical IP

Thiên Anh

The project covering 142.2ha in the central province's Nghi Son Economic Zone.

Thanh Hoa approves $56mln Vietnam–India high-tech pharmaceutical IP

Authorities in central Thanh Hoa province have approved the investment policy and selected investors for the first phase of the Vietnam–India High-Tech Pharmaceutical Industrial Park in the Nghi Son Economic Zone.

The project will cover about 142.2 hectares at Industrial Park No. 20 in Nghi Son Economic Zone, located in Cac Son commune. It has a total investment of VND1.47 trillion (over $56 million).

The project will have an operational period of 50 years from the date the State allocates or leases land to the investor.

The project will be carried out by a consortium of three investors, including Vietnam’s Anh Phat Group Joint Stock Company and two investors from India, including Sri Avantika Contractors Co., Ltd., and an individual investor.

Under the project’s financial structure, investors’ equity will account for 20% of the total investment, equivalent to VND294.69 billion, while the remaining 80%, or about VND1.18 trillion, will be mobilised from other sources.

Construction and commissioning of the project must be completed within 36 months from the date the investor is allocated or leased land by the State.

Attention
The original article is written and published on VnEconomy in Vietnamese, then translated into English by Askonomy – an AI platform developed by Vietnam Economic Times/VnEconomy – and published on En-VnEconomy. To read the full article, please use the Google Translate tool below to translate the content into your preferred language.
However, VnEconomy is not responsible for any translation by the Google Translate.

Google translateGoogle translate